安徽黄山胶囊股份有限公司2026年第一季度报告深度解读

一、业绩表现及财务概要

安徽黄山胶囊股份有限公司（证券代码：002817）近日披露了2026年第一季度报告。公司2026年一季度营业收入为95,787,626.93元，较上年同期下降19.53%。归属于上市公司股东的净利润为17,362,236.43元，同比下降7.83%。扣除非经常性损益的净利润为16,833,426.94元，同比下降7.49%。值得注意的是，经营活动产生的现金流量净额为-5,769,589.23元，较去年同期大幅下降176.92%，显示公司经营活动现金流压力显著增加。

二、关键财务指标变化及原因

• 货币资金期末较期初减少4,691.09万元，降幅达30.17%，主要系经营活动现金流净额减少和大额定期存单增加所致。
• 应收款项融资期末较期初增加3,544.23万元，增幅100.25%，主要源于银行承兑汇票增加。
• 预付款项期末较期初增加48.17万元，增幅231.69%，主要因各类预付款增加。
• 其他流动资产期末较期初减少202.38万元，降幅99.52%，系预缴税款减少。
• 在建工程减少215.93万元，降幅51.62%，因部分转为固定资产。
• 使用权资产减少16.51万元，降幅31.09%，主要系折旧所致。
• 合同负债增加75.55万元，增幅92.39%，系预收款增加。
• 其他流动负债增加9.82万元，增幅93.36%，系预收款对应销项税增加。
• 税金及附加同比增加31.34万元，增幅32.61%，主要随增值税增长。
• 投资收益同比增加2.80万元，增幅42.68%，系票据贴现减少。
• 信用减值损失同比减少142.37万元，降幅177.33%，系坏账减少。
• 资产减值损失同比增加12.18万元，增幅243.56%，主要为存货减值增加。
• 资产处置收益增加14.83万元，增幅3351.68%，因固定资产处置增加。
• 少数股东损益减少25.44万元，降幅185.92%，因非全资子公司净利润减少。
• 筹资活动现金流净额同比增加807.56万元，因分配股利减少。

三、股东结构变化及重要持股信息

• 报告期末公司普通股股东总数为18,494名。
• 山东鲁泰控股集团有限公司为最大股东，持股比例29.99%，持股数量为89,699,541股。
• 重要自然人股东余春明（8.06%）、余超彪（3.46%）为父子关系，系一致行动人。
• 外资机构如高盛公司、BARCLAYS BANK PLC均为前十大股东之一。

四、资产负债表及现金流情况

• 总资产为1,115,927,970.19元，较年初微增0.73%。
• 归属于上市公司股东的所有者权益为977,382,554.31元，增长1.80%。
• 流动负债为122,262,323.67元，较年初减少6.79%。
• 期末现金及现金等价物余额为43,116,840.08元，同比减少26.01%。

五、非经常性损益项目

• 非经常性损益合计528,809.49元，主要包括：非流动资产处置收益152,729.37元、政府补助458,500元、营业外收入10,899.44元，扣除所得税影响额93,319.32元。

六、投资者需关注的潜在风险及价格敏感信息

• 营业收入及净利润双双下滑，且经营活动现金流转负，显示主营业务面临较大压力。这一变化或将引发市场对公司盈利能力和现金流安全的担忧，属于典型的价格敏感信息。
• 货币资金大幅下降，加上高额的应收款项融资和预付款项增加，提示公司短期流动性管理值得持续关注。
• 存货减值增加、资产处置收益提升，显示公司存货管理和资产结构调整正在进行，可能对未来盈利产生影响。
• 公司筹资活动现金流大幅改善，但主要因分红减少，未来持续性尚需验证。

结论

2026年第一季度，安徽黄山胶囊股份有限公司主营业务收入和利润均出现下滑，且经营现金流为负，货币资金显著下降。上述核心业绩变动及流动性压力可能对公司估值和股价产生负面影响，投资者需密切关注公司后续业务调整、应收账款及现金流管理状况。此外，股东结构稳定，控股股东地位未变，无重大变动。

免责声明：本文根据安徽黄山胶囊股份有限公司2026年第一季度公开报告编写，仅供投资者参考，不构成任何投资建议。投资者据此操作，风险自负。公司实际经营情况及未来业绩可能受宏观经济、行业环境及公司自身管理等多重因素影响，请投资者保持理性、注意风险。

English Version

Detailed Review of Anhui Huangshan Capsule Co., Ltd. 2026 Q1 Report

1. Performance Overview and Financial Highlights

Anhui Huangshan Capsule Co., Ltd. (Stock Code: 002817) has released its Q1 2026 financial report. The company reported a revenue of RMB 95,787,626.93, down 19.53% year-on-year. Net profit attributable to shareholders was RMB 17,362,236.43, a decrease of 7.83% compared to the same period last year. Net profit excluding non-recurring items was RMB 16,833,426.94, down 7.49%. Notably, net cash flow from operating activities was negative RMB 5,769,589.23, a significant decline of 176.92% year-on-year, indicating substantial cash flow pressure from operations.

2. Key Financial Changes and Reasons

• Monetary funds at the end of the period decreased by RMB 46.91 million from the beginning, down 30.17%, mainly due to reduced operating cash inflow and increased large time deposits.
• Notes receivable financing increased by RMB 35.44 million, up 100.25%, mainly due to more bank acceptance bills received.
• Prepayments increased by RMB 481,700, up 231.69% due to higher various prepayments.
• Other current assets decreased by RMB 2.02 million, down 99.52%, mainly due to a reduction in prepaid taxes.
• Construction in progress decreased by RMB 2.16 million, down 51.62%, as some projects were transferred to fixed assets.
• Right-of-use assets decreased by RMB 165,100, down 31.09%, mainly due to depreciation.
• Contract liabilities increased by RMB 755,500, up 92.39%, due to higher advances from customers.
• Other current liabilities increased by RMB 98,200, up 93.36%, due to increased taxes on advances received.
• Taxes and surcharges increased by RMB 313,400, up 32.61%, in line with VAT growth.
• Investment income increased by RMB 28,000, up 42.68%, due to less bill discounting.
• Credit impairment losses decreased by RMB 1.42 million, down 177.33%, due to fewer bad debts.
• Asset impairment losses increased by RMB 121,800, up 243.56%, mainly due to increased inventory impairment.
• Asset disposal gains increased by RMB 148,300, up 3351.68%, due to more fixed asset disposals.
• Minority shareholders’ profit/loss decreased by RMB 254,400, down 185.92%, as net profit from non-wholly owned subsidiaries declined.
• Net cash flow from financing activities increased by RMB 8.08 million, mainly due to lower dividend payouts.

3. Shareholder Structure and Key Holdings

• The company had 18,494 ordinary shareholders at the end of the period.
• Shandong Lutai Holding Group Co., Ltd. is the largest shareholder with a 29.99% stake (89,699,541 shares).
• Key individual shareholders Yu Chunming (8.06%) and Yu Chaobiao (3.46%) are father and son, acting in concert.
• Foreign institutional shareholders such as Goldman Sachs and BARCLAYS BANK PLC are among the top ten shareholders.

4. Balance Sheet and Cash Flow

• Total assets reached RMB 1,115,927,970.19, up 0.73% from the beginning of the year.
• Shareholders’ equity attributable to listed company shareholders was RMB 977,382,554.31, up 1.80%.
• Current liabilities were RMB 122,262,323.67, down 6.79%.
• Ending cash and cash equivalents were RMB 43,116,840.08, down 26.01% year-on-year.

5. Non-Recurring Gains and Losses

• Total non-recurring gains and losses were RMB 528,809.49, mainly including: gain on disposal of non-current assets (RMB 152,729.37), government grants (RMB 458,500), and other non-operating income, less income tax effects.

6. Key Risks and Price-Sensitive Information for Investors

• Both revenue and net profit declined, and operating cash flow turned negative, indicating considerable pressure on core operations. This is a classic price-sensitive signal that could affect share valuation.
• Substantial drop in monetary funds, coupled with increased financing and prepayments, points to potential short-term liquidity management challenges.
• Increased inventory impairment and higher asset disposal gains show the company is adjusting asset structure, which may affect future profitability.
• Financing cash flow improved mainly due to reduced dividend payouts, and its sustainability remains to be seen.

Conclusion

In Q1 2026, Anhui Huangshan Capsule Co., Ltd. saw declines in both core business income and profit, with negative operating cash flow and a significant drop in cash holdings. These core performance changes and liquidity pressures could negatively impact company valuation and share price. Investors are advised to closely monitor subsequent business adjustments and management of receivables and cash flow. Shareholder structure remains stable, with no major changes in control.

Disclaimer: This article is based on the public Q1 2026 report of Anhui Huangshan Capsule Co., Ltd. and is for reference only. It does not constitute investment advice. Investors operate at their own risk. The company’s actual results and future performance may be affected by macroeconomic, industry, and internal management factors. Please remain prudent and aware of risks.

View 黄山胶囊 Historical chart here